Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Blood (2021) 137 (15): 2046–2056.

https://doi.org/10.1182/blood.2020006322

Published: 2021

Includes: Supplemental data

Journal Articles

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Christopher Pleyer, Mir A. Ali, Jeffrey I. Cohen, Xin Tian, Susan Soto, Inhye E. Ahn, Erika M. Gaglione, Pia Nierman, Gerald E. Marti, Charles Hesdorffer, Jennifer Lotter, Jeanine Superata, Adrian Wiestner, Clare Sun

Blood (2021) 137 (2): 185–189.

https://doi.org/10.1182/blood.2020008758

Published: 2021

Includes: Supplemental data

Journal Articles

Measurement of Serum microRNAs in US Veterans with Monoclonal Gammopathy of Undetermined Significance

Weixin Wang, PhD, Youn K Shim, PhD, Joel E Michalek, PhD, Emily Barber, BS, Layla M Saleh, MD PhD, Byeong Yeob Choi, PhD, Chen-Pin Wang, PhD, Norma Ketchum, MS, Rene Costello, MT, Gerald E Marti, MD PhD, Robert Vogt, PhD, Ola Landgren, MD PhD, Katherine R. Calvo, MD PhD

Blood (2018) 132 (Supplement 1): 5576.

https://doi.org/10.1182/blood-2018-99-114821

Published: 2018

Journal Articles

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

Blood (2018) 131 (21): 2357–2366.

https://doi.org/10.1182/blood-2017-12-820910

Published: 2018

Includes: Supplemental data

Journal Articles

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

Clare Sun, Xin Tian, Yuh Shan Lee, Sreenivasulu Gunti, Andrew Lipsky, Sarah E. M. Herman, Dalia Salem, Maryalice Stetler-Stevenson, Constance Yuan, Lela Kardava, Susan Moir, Irina Maric, Janet Valdez, Susan Soto, Gerald E. Marti, Mohammed Z. Farooqui, Abner L. Notkins, Adrian Wiestner, Georg Aue

Blood (2015) 126 (19): 2213–2219.

https://doi.org/10.1182/blood-2015-04-639203

Published: 2015

Includes: Supplemental data

Journal Articles

Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding

Youn K. Shim, Jane M. Rachel, Paolo Ghia, Jeff Boren, Fatima Abbasi, Antonis Dagklis, Geri Venable, Jiyeon Kang, Heba Degheidy, Fred V. Plapp, Robert F. Vogt, Jay E. Menitove, Gerald E. Marti

Blood (2014) 123 (9): 1319–1326.

https://doi.org/10.1182/blood-2013-08-523704

Published: 2014

Journal Articles

MBL: mostly benign lymphocytes, but…

Gerald E. Marti

Blood (2011) 118 (25): 6480–6481.

https://doi.org/10.1182/blood-2011-09-379073

Published: 2011

Journal Articles

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Susan L Slager, PhD, Mark C Lanasa, MD, PhD, Sallie D. Allgood, MS, Sara J Achenbach, Aaron Norman, MS, Celine M Vachon, PhD, Lynn Goldin, PhD, Jose F. Leis, MD, PhD, Neil Kay, MD, J. Brice Weinberg, MD, Kari Rabe, MS, Timothy G. Call, MD, James R Cerhan, MD, PhD, Tait D. Shanafelt, MD, Neil E Caporaso, MD, Gerald E Marti, MD, PhD, Curtis A. Hanson, MD

Blood (2011) 118 (21): 3881.

https://doi.org/10.1182/blood.V118.21.3881.3881

Published: 2011

Journal Articles

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

Blood (2011) 117 (6): 1911–1916.

https://doi.org/10.1182/blood-2010-09-308205

Published: 2011

Includes: Supplemental data

Journal Articles

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

Blood (2011) 117 (2): 563–574.

https://doi.org/10.1182/blood-2010-05-284984

Published: 2011

Includes: Supplemental data

Journal Articles

Rapid Clearance of Rituximab Contributes to the Continued High Incidence of Autoimmune Complications of Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Clifton C. Mo, MD, Mohammed Z.H. Farooqui, DO, Paul V. Beum, PhD, Ndegwa Njuguna, MD, Gerald E Marti, MD, PhD, Wyndham H. Wilson, MD, PhD, Ronald P. Taylor, PhD, Adrian U. Wiestner, MD, PhD

Blood (2010) 116 (21): 4628.

https://doi.org/10.1182/blood.V116.21.4628.4628

Published: 2010

Journal Articles

Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci

Blood (2010) 116 (21): 2443.

https://doi.org/10.1182/blood.V116.21.2443.2443

Published: 2010

Journal Articles

Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study

Huei-Ting Tsai, Neil E. Caporaso, Robert A. Kyle, Jerry A. Katzmann, Angela Dispenzieri, Richard B. Hayes, Gerald E. Marti, Maher Albitar, Paolo Ghia, S. Vincent Rajkumar, Ola Landgren

Blood (2009) 114 (24): 4928–4932.

https://doi.org/10.1182/blood-2009-08-237651

Published: 2009

Journal Articles

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Blood (2009) 114 (22): 1232.

https://doi.org/10.1182/blood.V114.22.1232.1232

Published: 2009

Journal Articles

Multimodal Bcl-2 Sub-Populations in CLL.

Heba A. Degheidy, MD, PhD, Shahinaz M. Gadalla, MD, PhD, Elizabeth Raveche, PhD, MA Stetler-Stevenson, MD, PhD, Gerald E. Marti, MD, PhD

Blood (2009) 114 (22): 4391.

https://doi.org/10.1182/blood.V114.22.4391.4391

Published: 2009

Journal Articles

The changing definition of CLL

Gerald E. Marti

Blood (2009) 113 (18): 4130–4131.

https://doi.org/10.1182/blood-2008-12-193656

Published: 2009

Journal Articles

High Incidence of Autoimmune Complications during Combined Fludarabine and Rituximab Therapy in CLL: Rapid Clearance of Rituximab as a Contributing Factor

Ndegwa Njuguna, MD, Paul V Beum, PhD, Berengere Vire, PhD, Gerald E Marti, MD, PhD, Therese White, RN, Wyndham H. Wilson, MD, PhD, Ronald P Taylor, PhD, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 4208.

https://doi.org/10.1182/blood.V112.11.4208.4208

Published: 2008

Journal Articles

The Role of the Microenvironment for CLL Proliferation and Survival: Gene Expression Profiling of Leukemic Cells Derived from Blood, Bone Marrow and Lymph Nodes Reveals the B-Cell Receptor and NF κB as Dominant Signaling Pathways

Yair Herishanu, MD, Berengere Vire, PhD, Delong Liu, PhD, Federica Gibellini, PhD, Gerald E Marti, MD, PhD, Therese White, RN, Ndegwa Njuguna, MD, Nalini Raghavachari, PhD, Poching Liu, PhD, Stefania Pittaluga, MD, PhD, Peter J Munson, PhD, Wyndham H. Wilson, MD, PhD, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 356.

https://doi.org/10.1182/blood.V112.11.356.356

Published: 2008

Journal Articles

Molecular Effects of Rituximab on CLL Cells In Vivo : Rapid Increase in Serum Interferon gamma, Induction of a Distinct Tumor Cell Gene Expression Signature and Loss of CD20 Expression.

Adrian Wiestner, MD, PhD, Elinor Lee, BA, Berengere Vire, PhD, Federica Gibellini, PhD, Ndegwa Njuguna, MD, Yair Herishanu, MD, Delong Liu, PhD, Peter Munson, PhD, Nalini Raghavachari, PhD, Therese White, RN, Gerald E. Marti, MD, PhD, Wyndham H. Wilson, MD, PhD

Blood (2007) 110 (11): 2048.

https://doi.org/10.1182/blood.V110.11.2048.2048

Published: 2007

Journal Articles

Evidence of Pre-Diagnostic Monoclonality in Blood Obtained up to 6.4 Years Preceding Diagnosis of Chronic Lymphocytic Leukemia (CLL).

Ola Landgren, MD, PhD, Maher X. Albitar, MD, PhD, Wanlong X. Ma, PhD, Fatima R. Abbasi, PhD, Richard B. Hayes, PhD, Gerald E. Marti, MD, PhD, Neil E. Caporaso, MD

Blood (2007) 110 (11): 3082.

https://doi.org/10.1182/blood.V110.11.3082.3082

Published: 2007

NARROW

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Measurement of Serum microRNAs in US Veterans with Monoclonal Gammopathy of Undetermined Significance

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding

MBL: mostly benign lymphocytes, but…

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

Rapid Clearance of Rituximab Contributes to the Continued High Incidence of Autoimmune Complications of Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci

Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Multimodal Bcl-2 Sub-Populations in CLL.

The changing definition of CLL

High Incidence of Autoimmune Complications during Combined Fludarabine and Rituximab Therapy in CLL: Rapid Clearance of Rituximab as a Contributing Factor

The Role of the Microenvironment for CLL Proliferation and Survival: Gene Expression Profiling of Leukemic Cells Derived from Blood, Bone Marrow and Lymph Nodes Reveals the B-Cell Receptor and NF κB as Dominant Signaling Pathways

Molecular Effects of Rituximab on CLL Cells In Vivo : Rapid Increase in Serum Interferon gamma, Induction of a Distinct Tumor Cell Gene Expression Signature and Loss of CD20 Expression.

Evidence of Pre-Diagnostic Monoclonality in Blood Obtained up to 6.4 Years Preceding Diagnosis of Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only